Metabolic regulation of erythrocyte development and disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological mechanisms without systematic methodology or new clinical data
PubMed 38237718 · doi:10.1016/j.exphem.2024.104153
What was done
This narrative review synthesizes current knowledge on the metabolic regulation of erythropoiesis across developmental stages (lineage specification, proliferation, differentiation, and terminal maturation) and reviews metabolic dysfunction in red blood cell disorders, including pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, sickle cell disease, and beta-thalassemia.
What was found
The abstract reports no numerical data. It qualitatively describes metabolic transitions required during mammalian erythrocyte maturation, including the loss of mitochondria with a transition to glycolysis, organelle and nuclear extrusion, elevated heme and hemoglobin synthesis, and enhanced antioxidant requirements to safeguard hemoglobin.
Why it matters
Elucidating stage-specific metabolic dependencies during red blood cell formation identifies potential metabolic targets for treating inherited hemoglobinopathies and hemolytic anemias.
Limits
This is a narrative review with no systematic search criteria, meta-analytic pooling, or original experimental/clinical datasets reported in the abstract. Clinical viability of proposed metabolic interventions is not established.
Cited by
- supports Red blood cells lack mitochondria and must use glucose for their metabolism.